Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Sanofi Benefits From Stockpiling In Q1, Predicts Long-Term Uplift In Supplements Demand

Apr 27 2020

• By Tom Gallen

Related Content

OTC Zantac Recall: Sanofi Heeds To Potential Ranitidine Contaminant

Oct 18 2019

Sanofi Forms Standalone Consumer Healthcare Unit: Prelude To Spin-Off?

Dec 10 2019

Sanofi Counts On OTC Switches Adding $1bn In Consumer Revenues By 2026

Dec 12 2019

Sanofi Developing COVID-19 OTC Test For Global Roll-Out

Apr 17 2020

Supplementation During COVID-19? An Industry Perspective

Apr 01 2020

Additional Topics

International Europe United States Sales & Earnings Coronavirus COVID-19 Dietary Supplements OTC Drugs Consumer

More from Earnings

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window